Recommended Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Journal of Clinical Oncology | Phase Ib Study Results of an EGFR-HER3 Bispecific ADC in Extensive-Stage Small Cell Lung Cancer
2026-10-09
【Frontier Express】Nature | GPCR-TfR1 Targeted Chimeras (GTACs) Achieve Potent Antagonism via Reprogramming Receptor Trafficking and Lysosomal Degradation
2026-10-09
【Frontier Express】Antibodies | B Cells and Tumor Immunometabolism: Emerging Insights into Immune Regulation and Therapeutic Resistance
2026-10-09
【Frontier Express】Nature Communications | Dysfunction of Tertiary Lymphoid Structures in the Muscularis Propria of Gastric Cancer and the Immunosuppressive Mechanism Mediated by PLA2G2A
2026-10-08
【Frontier Express】Theranostics | PEGylated IL2 Combined with Targeted Radiotherapy and Anti-PD-1 Enhances CD8+ T Cell Memory Response in Head and Neck Squamous Cell Carcinoma
2026-10-07
【Frontier Express】Advanced Science | Anti-EGFR Nanobody-Mediated Delivery of RIBOTACs for miR-21 Degradation in Pancreatic Cancer Therapy
2026-10-07
【Frontier Express】Neuro-Oncology | YBX1 and YBX3 as Novel Targets for Glioma Immunotherapy
2026-10-06






